Form 4 for CC Chemours Co
Accepted 2024-05-10 00:00:00 ET · period of report 2024-05-08 · accession 0001062993-24-009877 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-10 | 2024-05-08 | CC | Familiar Calderon Gerardo | Pres Advanced Performance Mat | A - Grant | $0.00 | +5,909 | 23.7K | +33% | $0 |
| DM | 2024-05-10 | 2024-05-08 | CC | Familiar Calderon Gerardo | Pres Advanced Performance Mat | A - Grant | $0.00 | +32.2K | 16.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-08 | A | A | 5,909 | $0.00 | 23,727.88 | D | — | — | (F1) Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-05-08 | A | A | 15,807 | $0.00 | 15,807 | D | $27.50 · — to 2034-05-08 | 15,807 Common Stock | (F3) These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. |
| 3 | Derivative | Performance Stock Option (Right to Buy) | 2024-05-08 | A | A | 16,439 | $0.00 | 16,439 | D | $30.25 · — to 2034-05-08 | 16,439 Common Stock | (F4) Represents a 10 percent premium above the closing price of the Company common stock on the date of grant. (F3) These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. |